Catinazzo Thomas

Chief Financial OfficerRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jan 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$268K
Net Open-Market Flow
-$268K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2025Sell(S)21K$4.42$92K379K
Jan 29, 2025Sell(S)2K$4.55$10K400K
Jan 28, 2025Sell(S)34K$4.63$156K265K
Jan 28, 2025Grant(A)139K$0402K
Jan 28, 2025Sell(S)2K$4.63$11K263K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-011327) within minutes of acceptance. Every field above traces to the original document. Verify it directly: